Treatment of mandibular malignant fibrous histiocytoma during pregnancy.
Otsuka
K
K
Department of Oral and Maxillofacial Surgery, Ehime University School of Medicine, Japan.
Hamakawa
H
H
Sumida
T
T
Tanioka
H
H
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002585:Cesarean Section; D017024:Chemotherapy, Adjuvant; D003606:Dacarbazine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D018219:Histiocytoma, Benign Fibrous / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use; D008339:Mandibular Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D015080:Mesna / Q000627:therapeutic use; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*
D003606:Dacarbazine; D004317:Doxorubicin; D015080:Mesna; D007069:Ifosfamide